Our advisory work starts from a position of respect
for our clients' organization, people,
products and science.
We have devoted our careers to the life
sciences industry and have the deepest respect
and admiration for the participants in it.
OUR TRACK RECORD
We are a very active advisor in the market.
Torreya Partners has successfully closed over
100 assignments since our founding in 2007.
We often take an operating perspective
to strategic and transaction work.
Partial Royalty Monetization
May 30-31, 2017
Boston CEO Conference
June 2, 2017
Wilson Sonsini Device Conf
San Francisco, CA
June 2-6, 2017
ASCO - Annual Meeting
December 21, 2016
XOMA Announces up to $22 Million Generated from Sale of Royalty Streams from Two License Agreements to HealthCare Royalty Partners and Provides Corporate Update
December 15, 2016
Opiant Pharmaceuticals, Inc. Announces NARCAN® Nasal Spray Royalty Monetization
October 25, 2015
Everstone Capital Invests Rs 222 crore in Rubicon Research